Equity Capital Markets

Company · CIK 1715028

Axium Pharmaceuticals Inc.

CIK1715028 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inNC
Business addressNC
Listedno ticker on SEC record today
First annual or quarterly reportnone on EDGAR

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-220076
First-time registrationEffective
 2017-08-212018-01-238

Filings

8
FiledFilingRegistrationAccession
2018-01-23EFFECTDeclared effective 333-2200769999999995-18-000185
2018-01-11S-1/AAmendment 333-2200760001707451-18-000003
2017-12-28S-1/AAmendment 333-2200760001707451-17-000024
2017-12-13S-1/AAmendment 333-2200760001707451-17-000020
2017-11-30S-1/AAmendment 333-2200760001707451-17-000017
2017-11-13S-1/AAmendment 333-2200760001707451-17-000014
2017-10-05S-1/AAmendment 333-2200760001707451-17-000006
2017-08-21S-1Registration filed 333-2200760001707451-17-000003

All filings of this company · CSV